Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eugene Sun

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Antimicrobial Agents and Chemotherapy|April 8, 2015
A thorough QT study to evaluate the effects of therapeutic and supratherapeutic doses of delafloxacin on cardiac repolarizationJeffrey S Litwin, Michael S Benedict, Michael D Thorn, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 9, 2025
Corrigendum to "Candidate anti-tuberculosis medicines and regimens under clinical evaluation" [Clin Microbiol Infect 30(9) (2024) 1131-1138]Michael Hoelscher, David Barros-Aguirre, Masoud Dara, et al.
Journal of Virology|March 29, 2003
A novel antiviral intervention results in more accurate assessment of human immunodeficiency virus type 1 replication dynamics and T-cell decay in vivoMartin Markowitz, Michael Louie, Arlene Hurley, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 23, 2024
Candidate anti-tuberculosis medicines and regimens under clinical evaluationMichael Hoelscher, David Barros-Aguirre, Masoud Dara, et al.
Antimicrobial Agents and Chemotherapy|August 28, 2024
Pharmacokinetics and safety of TBAJ-876, a novel antimycobacterial diarylquinoline, in healthy subjectsAntonio Lombardi, Fran Pappas, Jerry Nedelman, et al.
Journal of Community Health|September 29, 2011
Community health workers and medicaid managed care in New MexicoDiane Johnson, Patricia Saavedra, Eugene Sun, et al.
The American Journal of Managed Care|February 12, 2021
Leveraging longitudinal clinical laboratory results to improve prenatal careRichard VanNess, Kathleen M Swanson, David G Grenache, et al.
The Journal of Infectious Diseases|January 1, 2004
Incidence of resistance in a double-blind study comparing lopinavir/ritonavir plus stavudine and lamivudine to nelfinavir plus stavudine and lamivudineDale J Kempf, Martin S King, Barry Bernstein, et al.
Antiviral Therapy|December 19, 2002
Analysis of the virological response with respect to baseline viral phenotype and genotype in protease inhibitor-experienced HIV-1-infected patients receiving lopinavir/ritonavir therapyDale J Kempf, Jeffrey D Isaacson, Martin S King, et al.
PLOS Global Public Health|October 18, 2023
Baseline and acquired resistance to bedaquiline, linezolid and pretomanid, and impact on treatment outcomes in four tuberculosis clinical trials containing pretomanidJuliano Timm, Anna Bateson, Priya Solanki, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Antimicrobial Agents and Chemotherapy|April 8, 2015
A thorough QT study to evaluate the effects of therapeutic and supratherapeutic doses of delafloxacin on cardiac repolarizationJeffrey S Litwin, Michael S Benedict, Michael D Thorn, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 9, 2025
Corrigendum to "Candidate anti-tuberculosis medicines and regimens under clinical evaluation" [Clin Microbiol Infect 30(9) (2024) 1131-1138]Michael Hoelscher, David Barros-Aguirre, Masoud Dara, et al.
Journal of Virology|March 29, 2003
A novel antiviral intervention results in more accurate assessment of human immunodeficiency virus type 1 replication dynamics and T-cell decay in vivoMartin Markowitz, Michael Louie, Arlene Hurley, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 23, 2024
Candidate anti-tuberculosis medicines and regimens under clinical evaluationMichael Hoelscher, David Barros-Aguirre, Masoud Dara, et al.
Antimicrobial Agents and Chemotherapy|August 28, 2024
Pharmacokinetics and safety of TBAJ-876, a novel antimycobacterial diarylquinoline, in healthy subjectsAntonio Lombardi, Fran Pappas, Jerry Nedelman, et al.
Journal of Community Health|September 29, 2011
Community health workers and medicaid managed care in New MexicoDiane Johnson, Patricia Saavedra, Eugene Sun, et al.
The American Journal of Managed Care|February 12, 2021
Leveraging longitudinal clinical laboratory results to improve prenatal careRichard VanNess, Kathleen M Swanson, David G Grenache, et al.
The Journal of Infectious Diseases|January 1, 2004
Incidence of resistance in a double-blind study comparing lopinavir/ritonavir plus stavudine and lamivudine to nelfinavir plus stavudine and lamivudineDale J Kempf, Martin S King, Barry Bernstein, et al.
Antiviral Therapy|December 19, 2002
Analysis of the virological response with respect to baseline viral phenotype and genotype in protease inhibitor-experienced HIV-1-infected patients receiving lopinavir/ritonavir therapyDale J Kempf, Jeffrey D Isaacson, Martin S King, et al.
PLOS Global Public Health|October 18, 2023
Baseline and acquired resistance to bedaquiline, linezolid and pretomanid, and impact on treatment outcomes in four tuberculosis clinical trials containing pretomanidJuliano Timm, Anna Bateson, Priya Solanki, et al.
Pageof 4